HYPERSENSITIVITY TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS

被引:48
作者
ZIAAMIRHOSSEINI, P
HARRIS, RZ
BRODSKY, FM
BENET, LZ
机构
关键词
D O I
10.1038/nm0195-2b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:2 / 4
页数:3
相关论文
共 14 条
[1]   DRUG DISCONTINUATIONS IN THE UNITED-KINGDOM AND THE UNITED-STATES, 1964 TO 1983 - ISSUES OF SAFETY [J].
BAKKE, OM ;
WARDELL, WM ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) :559-567
[2]   PREDICTABILITY OF THE COVALENT BINDING OF ACIDIC DRUGS IN MAN [J].
BENET, LZ ;
SPAHNLANGGUTH, H ;
IWAKAWA, S ;
VOLLAND, C ;
MIZUMA, T ;
MAYER, S ;
MUTSCHLER, E ;
LIN, ET .
LIFE SCIENCES, 1993, 53 (08) :PL141-PL146
[3]  
BRETZA JA, 1985, WESTERN J MED, V143, P55
[4]  
COOK DJ, 1988, CAN MED ASSOC J, V138, P1029
[5]  
DING A, IN PRESS DRUG METAB
[6]  
DING A, 1993, P NATL ACAD SCI USA, V93, P3797
[7]   SUPROFEN-RELATED NEPHROTOXICITY - A DISTINCT CLINICAL SYNDROME [J].
HART, D ;
WARD, M ;
LIFSCHITZ, MD .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :235-238
[8]   DICLOFENAC-ASSOCIATED HEPATOTOXICITY [J].
HELFGOTT, SM ;
SANDBERGCOOK, J ;
ZAKIM, D ;
NESTLER, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (20) :2660-2662
[9]   ADVERSE DRUG-INTERACTIONS WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) - RECOGNITION, MANAGEMENT AND AVOIDANCE [J].
JOHNSON, AG ;
SEIDEMAN, P ;
DAY, RO .
DRUG SAFETY, 1993, 8 (02) :99-127
[10]  
MCKINNON GE, 1989, RES COMMUN CHEM PATH, V66, P339